KLOW Peptide Blend: GHK-Cu, BPC-157, TB-500 & KPV Guide [2026]
KLOW is a four-peptide blend built for tissue repair, inflammation control, and skin and gut health. This guide breaks down the standard 80 mg ratio, each component, reconstitution and dosing, realistic benefits, side effects, and how KLOW differs from the simpler GLOW blend.
Quick definition: KLOW = KPV + GHK-Cu + BPC-157 + TB-500. A typical commercial vial is 80 mg total: 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500, and 10 mg KPV.
What Is the KLOW Peptide Blend?
KLOW is a combination product that puts four research peptides into one vial. The acronym maps to its four components: KPV, plus the three peptides already found in the popular GLOW blend (GHK-Cu, BPC-157, and TB-500). The idea is to cover several recovery mechanisms at once: collagen and skin remodeling, soft-tissue and tendon repair, blood-vessel formation, and inflammation control.
Unlike a single peptide, KLOW is sold as a fixed ratio. You cannot dial up the BPC-157 without also raising your copper load from GHK-Cu, because all four peptides are reconstituted together. That trade-off is the central thing to understand before using it: KLOW is convenient, but it is not flexible.
None of the four peptides in KLOW are FDA-approved drugs. The blend is sold through research-chemical vendors and some compounding channels, and quality varies sharply between sources. Read our notes on peptide testing and purity and grey-market risks before buying.
The Standard 80 mg KLOW Ratio
The most widely sold KLOW vial totals 80 mg and uses a fixed mass ratio. GHK-Cu makes up the bulk of the blend, with the other three peptides at 10 mg each:
| Peptide | Amount | Primary Role |
|---|---|---|
| GHK-Cu | 50 mg | Collagen, skin remodeling, anti-aging |
| BPC-157 | 10 mg | Soft-tissue and gut healing, angiogenesis |
| TB-500 | 10 mg | Cell migration, flexibility, recovery |
| KPV | 10 mg | Anti-inflammatory, immune and gut support |
Because GHK-Cu dominates the blend, most providers dose KLOW by its GHK-Cu content. That also means the copper load is the limiting factor on frequency. If you want to control BPC-157 or TB-500 independently, separate vials (or the BPC-157 + TB-500 blend) give more control than a fixed four-way mix.
The Four Components Explained
GHK-Cu (Copper Tripeptide)
GHK-Cu is a naturally occurring copper-binding tripeptide. Plasma levels fall with age, tracking with slower healing and visible skin aging. It drives collagen and elastin synthesis, supports wound remodeling, and has antioxidant activity. In KLOW it is the largest fraction and the main reason the blend is used for skin and anti-aging. See our dedicated GHK-Cu guide, benefits, and dosage pages.
BPC-157
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. It is the most-discussed healing peptide for tendon, ligament, and gut repair, partly through promoting new blood-vessel formation (angiogenesis). Inside KLOW it carries the soft-tissue and gut-lining repair workload. Details in our BPC-157 benefits and dosage guides.
TB-500 (Thymosin Beta-4 Fragment)
TB-500 is a synthetic version of a region of thymosin beta-4. It promotes cell migration and tissue regeneration, and is used for flexibility and recovery after injury. BPC-157 and TB-500 are frequently paired because their repair mechanisms are complementary; KLOW keeps that pairing and adds copper and anti-inflammatory action. See TB-500 dosage and the BPC-157 vs TB-500 comparison.
KPV
KPV is the tripeptide tail of alpha-melanocyte-stimulating hormone (alpha-MSH). It is a focused anti-inflammatory, with most interest aimed at gut inflammation and epithelial and mucosal tissue. KPV is what separates KLOW from GLOW, pushing the blend toward inflammatory and gut conditions rather than skin alone. More in our KPV benefits and KPV for gut health guides.
Reported Benefits of KLOW
KLOW is marketed as an all-in-one recovery and rejuvenation blend. The claimed benefits track the known actions of its four peptides. Evidence for the individual peptides ranges from animal studies to anecdotal human reports; there are no controlled trials of the blend itself.
- •Skin and anti-aging: firmer skin, improved texture, and wrinkle reduction driven mostly by the GHK-Cu fraction.
- •Soft-tissue and joint recovery: faster perceived healing of tendons, ligaments, and muscle from BPC-157 and TB-500.
- •Gut support: reduced gut inflammation and symptom relief attributed to BPC-157 and KPV.
- •Systemic inflammation control: KPV and GHK-Cu both have anti-inflammatory and antioxidant activity.
- •Hair and wound healing: GHK-Cu is widely used for hair and scalp support.
If your only target is cosmetic skin improvement, see peptides for skin and copper peptides for skin. For broad recovery goals, our best peptides for healing guide puts KLOW in context.
KLOW Dosing and Reconstitution
KLOW arrives as a lyophilized powder and must be reconstituted with bacteriostatic water before use. A practical approach for the 80 mg vial is 2-3 mL of bacteriostatic water, which keeps injection volumes small while making the math easy. Because the four peptides are fixed in ratio, you set your dose by the GHK-Cu content and accept the BPC-157, TB-500, and KPV that come with it.
Clinics that work with the standard vial commonly target 1-2 mg of GHK-Cu equivalent per subcutaneous injection, several times per week. Run your exact vial size and water volume through our reconstitution calculator or the blend calculator to convert milligrams into insulin-syringe units. For injection technique and site rotation, see how to inject peptides and injection sites.
Storage: keep the lyophilized vial in the freezer and the reconstituted vial refrigerated, away from light. See our peptide storage guide for shelf-life details.
KLOW vs GLOW: Which Should You Use?
The practical difference is one peptide. GLOW is GHK-Cu + BPC-157 + TB-500 and is aimed at skin, hair, and healing. KLOW adds KPV, which extends the blend toward gut inflammation and immune-driven conditions.
- •Choose GLOW if your goal is cosmetic: skin quality, fine lines, and general recovery.
- •Choose KLOW if you also want gut or systemic anti-inflammatory support and are comfortable with the added KPV.
- •Choose single peptides if you need to control individual doses, since both blends lock you into a fixed ratio.
Side Effects and Safety
Reported side effects across the four peptides are usually mild and local: injection-site redness, itching, or swelling, and occasional fatigue. The GHK-Cu fraction carries a copper load, so frequent high dosing is the main thing to monitor; signs of excess copper can include nausea or lightheadedness. KPV and BPC-157 are generally well tolerated in user reports.
The larger risk is product quality. Because none of these peptides are FDA-approved, blends can be underdosed, contaminated, or mislabeled. Review our BPC-157 side effects and KPV side effects pages, and confirm whether these peptides are legal in your situation before purchasing.
Frequently Asked Questions About KLOW
KLOW is a four-peptide blend that combines GHK-Cu, BPC-157, TB-500, and KPV in a single vial. The name is an acronym of its components. It is marketed for tissue repair, inflammation control, skin and gut health, and general recovery. The most common commercial vial is an 80 mg blend: 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500, and 10 mg KPV.
GLOW is a three-peptide blend (GHK-Cu, BPC-157, TB-500) focused on skin, hair, and healing. KLOW adds KPV, an anti-inflammatory tripeptide derived from alpha-MSH, which extends the blend toward gut health and immune-driven inflammation. KLOW is essentially GLOW plus KPV. If your goal is purely cosmetic skin rejuvenation, GLOW is often enough; if you also want gut or systemic inflammation support, KLOW adds that fourth lever.
There is no FDA-approved dose because KLOW is not an approved product. Clinics that use the standard 80 mg vial commonly dose by GHK-Cu content, often 1-2 mg of GHK-Cu equivalent per injection, which corresponds to roughly 16-32 units on a U-100 insulin syringe after standard reconstitution. Because four peptides are fixed in one ratio, you cannot adjust one without changing all of them. Always follow the protocol from your prescribing provider.
KLOW ships as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water. A common approach for an 80 mg vial is 2-3 mL of bacteriostatic water, which keeps the draw volume manageable. Use our reconstitution calculator to convert your chosen concentration into syringe units, and store the reconstituted vial refrigerated.
KLOW is most often subcutaneous injection because BPC-157, TB-500, and KPV are not well absorbed through intact skin. GHK-Cu alone is used topically in serums, but the other three peptides in KLOW need injection or, in KPV's case, sometimes oral capsules for gut-localized effects. The blended vial is designed for subcutaneous use.
Reported side effects are generally mild: injection-site redness, itching, or irritation, temporary fatigue, and (from the GHK-Cu copper load) occasional lightheadedness. Because KLOW stacks four peptides, the copper content from a 50 mg GHK-Cu portion is the main thing to watch with frequent dosing. None of the four peptides are FDA-approved, and product purity varies widely by source.
The individual peptides occupy a regulatory grey area. BPC-157 and KPV have been the subject of FDA compounding restrictions, and none of the four are approved drugs. KLOW is typically sold as a research chemical or through compounding channels. Legality depends on how it is sold and used. See our guides on whether peptides are legal and the grey-market risks before purchasing.
Timelines depend on the goal. Skin texture and minor healing changes from the GHK-Cu and BPC-157 fractions are often reported within 2-4 weeks. Tendon, gut, or deeper tissue recovery driven by BPC-157 and TB-500 typically needs 4-8 weeks of consistent use. KPV's anti-inflammatory effect on gut symptoms can appear within days to a couple of weeks for some users.
Disclaimer
This guide is educational and not medical advice. KLOW and its component peptides are not FDA-approved drugs. Consult a qualified healthcare provider before starting any peptide protocol, and source any product only through reputable, tested channels.